3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioblastoma
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
Specimen Handling
3
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Biopsy
2
talimogene laherparepvec
1
peposertib
1
liposomal doxorubicin
1
fludarabine
1
aldesleukin
1
X-Rays
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Ipilimumab
1
Histamine H2 Antagonists
1
Famotidine
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
pazopanib
×
30 days
×
Clear all
No trials found.